(Q44506139)

English

Systemic immunization with an epitope-based vaccine elicits a Th1-biased response and provides protection against Helicobacter pylori in mice

scientific article published on 6 November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Systemic immunization with an epitope-based vaccine elicits a Th1-biased response and provides protection against Helicobacter pylori in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

0 references

Helicobacter pylori

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Hai-Bo Li

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Jin-Yong Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Ya-Fei He

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Li Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Bin Li

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Kai-Yun Liu

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Wu-Chen Yang

7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Zhuo Zhao

8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Quan-Ming Zou

9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Chao Wu

10

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

6 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

120-126

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Helicobacter infection and gastric neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Cardiovascular risk factors in subjects with Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Vaccinating against Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Development of vaccines against Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Poliovirus replicons encoding the B subunit of Helicobacter pylori urease protect mice against H. pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Protection against Helicobacter pylori infection in mongolian gerbil by intragastric or intramuscular administration of H. pylori multicomponent vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

T cell epitope-based peptide-DNA dual vaccine induces protective immunity against Schistosoma japonicum infection in C57BL/6J mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Epitope-based vaccines: an update on epitope identification, vaccine design and delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

The CD4+ T cell-mediated IFN-gamma response to Helicobacter infection is essential for clearance and determines gastric cancer risk.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Evaluation of DNA extraction methods from mouse stomachs for the quantification of H. pylori by real-time PCR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Systematic identification of immunodominant CD8+ T-cell responses to influenza A virus in HLA-A2 individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Back to the future: covalent epitope-based HIV vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

In silico CD4+ T-cell epitope prediction and HLA distribution analysis for the potential proteins of Neisseria meningitidis Serogroup B--a clue for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Using epitope predictions to evaluate efficacy and population coverage of the Mtb72f vaccine for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

CpG DNA as a Th1 trigger

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

The clinical grade maturation cocktail monophosphoryl lipid A plus IFNgamma generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Local immunoglobulin G antibodies in the stomach may contribute to immunity against Helicobacter infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Systemic Th1 immunization of mice against Helicobacter pylori infection with CpG oligodeoxynucleotides as adjuvants does not protect from infection but enhances gastritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.091

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.10.091

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44506139&oldid=2025937420"